Community/Retail

Although only 1 biosimilar has been approved in the United States thus far, pharmacists can expect to see a lot more action in this space in the next few years.

Because many antiepileptic drugs have teratogenic potential, health care providers commonly recommend contraceptives to women with epilepsy.

Nearly 40% of the total population will complain of chronic cough over the course of their lifetime.

The Academy of Managed Care Pharmacy urges the full Senate to pass the Comprehensive Addiction and Recovery Act of 2016" with a provision that tackles the issue of opioid abuse and diversion among Medicare Part D beneficiaries.

ASHP today announced the release of two new educational activities focused on antimicrobial stewardship in a virtual poster format.

ASHP has published new guidelines on pharmacist involvement in HIV care in the April 1 edition of AJHP, ASHP's peer-reviewed, scholarly publication.

Between 10% and 15% of Americans have at least 1 chronic sleep disorder, and insomnia is the most common complaint.

Julie Dopheide, PharmD, BCPP, FASHP, outlines several counseling points for treating patients with depression, anxiety and insomnia.

Julie Dopheide, PharmD, BCPP, FASHP, describes sleep hygiene recommendations pharmacists can give to patients experiencing insomnia.

Researchers find plausible biological link between the Zika virus and microcephaly.

E-cigarette use among adults and adolescents has increased since 2010.

Jon Roth, CEO of the California Pharmacists Association, offers guidance and advice for state pharmacy associations with respect to naloxone dispensing laws.

Registration is now open to welcome volunteers from across Michigan and the Midwest to the 2016 Meijer LPGA Classic for Simply Give, which will be held June 14-19 at Blythefield Country Club.

In an effort to curb the spread of Zika virus disease in Puerto Rico, Walgreens is collaborating with the Centers for Disease Control and Prevention and the CDC Foundation to educate the public on preventive steps to avoid Zika.

CVS Health has announced that it will expand access to the opioid overdose-reversal medication naloxone at the end of March at its CVS Pharmacy locations in eight new states.

Transgender patients have unique health needs, but few health care professionals have received adequate training on how to best care for these patients.

A recent government report highlighted the role pharmacists play in promoting patient safety within ambulatory settings.

The FDA has approved Teligent Inc's abbreviated new drug application for desoximetasone ointment USP 0.25%, which is the generic equivalent of Taro Pharmaceuticals' Topicort Ointment.

Should a pharmacist-in-charge be held liable for a technician's theft? Can a pharmacist who is afraid of needles be fired for not providing immunizations?

Patients with schizophrenia and autism exhibit low levels of vitamin B12 in the brain, suggesting that these disorders could be related to poor B12 uptake from the blood into the brain.

Neil Williams, PharmD, CPP, Clinical Pharmacist Coordinator for Community Care of North Carolina, discusses the key components of an effective pharmacy team.

Dan Benamoz, RPh, President and CEO of Pharmacy Development Services, discusses the competitive advantages that independent pharmacies have over their retail pharmacy counterparts.

This weekly video program highlights the latest in pharmacy news, product news, and more.

Neil Williams, PharmD, CPP, Clinical Pharmacist Coordinator for Community Care of North Carolina, discusses how pharmacists can better utilize their pharmacy technicians.

New data from the US Centers for Medicare and Medicaid Services show an improvement in the number of Medicare Part D beneficiaries who have access to preferred cost-sharing pharmacies.

Overweight or obese women may experience unique difficulties with their reproductive health medications.

Amgen has submitted a supplemental biologics license application to the FDA for blinatumomab (Blincyto).

To better understand the risks of Essure, a permanent method of birth control, the FDA has called for a new mandatory clinical study to look at its risks.